Kringle Pharma, Inc.

4884・Growth Market・Pharmaceuticals

Official website

Kringle Pharma, Inc.

4884・Growth Market・Pharmaceuticals

Official website

Kringle Pharma, Inc.4884

Reference Indicators

Market Cap

24¥100M

P/E (Forecast)

—

P/B

1.8x

Dividend Yield (Forecast)

0.00%

ROE

-71.6%

EV/EBITDA

—

Financial Summary

Unit: ¥M

Item	2021Sep 2021	2022Sep 2022	2023Sep 2023	2024Sep 2024	2025Sep 2025
Net Sales	289	391	69	80	72
Gross Profit	218	303	69	80	72
SG&A Expenses	576	729	958	897	981
Operating Income	-357	-426	-888	-817	-909
Non-operating Income	82	104	43	62	1
Non-operating Expenses	24	8	7	—	6
Ordinary Income	-299	-330	-852	-754	-914
Pre-tax Income	-299	-330	-852	-754	-914
Income Taxes	1	1	1	1	1
Net Income	-301	-331	-854	-756	-916
Gross Margin	75.3%	77.4%	100.0%	100.0%	100.0%
Operating Margin	-123.5%	-108.8%	-1283.4%	-1021.9%	-1259.4%
ROA	-11.4%	-10.3%	-32.6%	-27.4%	-44.1%
ROE	-12.0%	-11.9%	-42.6%	-36.2%	-71.6%